Minerva Neurosciences, Inc. (NERV)
Market: NASD |
Currency: USD
Address: 1500 District Avenue
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Show more
📈 Minerva Neurosciences, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
100-200%
-
Net Income Growth Range (1Y):
100-200%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2022 |
- |
$0.125000 |
- |
2022-06-21 |
- |
Stock split |
|
Total Amount for 2022: $0.125000 |
📅 Earnings & EPS History for Minerva Neurosciences, Inc.
| Date | Reported EPS |
|---|
| 2025-08-05 (estimated upcoming) | - |
| 2025-05-13 | -0.5 |
| 2025-02-25 | -0.56 |
| 2024-11-05 | 2.97 |
| 2024-08-06 | -1.09 |
| 2024-05-01 | -1.13 |
| 2023-11-06 | -1.03 |
| 2023-08-01 | -1.12 |
| 2023-05-15 | -1.31 |
| 2023-03-08 | -1.26 |
| 2022-11-09 | -1.29 |
| 2022-08-09 | -1.63 |
| 2022-05-04 | -1.84 |
| 2022-03-01 | -4 |
| 2021-11-08 | -1.76 |
| 2021-08-02 | -2 |
| 2021-05-12 | -1.68 |
| 2021-03-08 | -1.36 |
| 2020-11-02 | -1.52 |
| 2020-08-03 | 5.84 |
| 2020-05-04 | -2.48 |
| 2020-03-09 | -6.16 |
| 2019-11-04 | -2.88 |
| 2019-08-05 | -2.56 |
| 2019-05-06 | -3.28 |
📰 Related News & Research
No related articles found for "minerva neurosciences".
